Hugel, a Kosdaq-listed medical aesthetics company, said Tuesday that it has obtained product approvals for its botulinum toxin (BTX), Letybo, in Lithuania, Bulgaria, Iceland, and Croatia.With this approval, Hugel is rapidly expanding its market by entering 30 European countries, including Germany, t
Bio
Kim Jung-chul
2024.01.16 10:28